Blue Owl Capital Holdings LP Larimar Therapeutics, Inc. Transaction History
Blue Owl Capital Holdings LP
- $303 Million
- Q3 2024
A detailed history of Blue Owl Capital Holdings LP transactions in Larimar Therapeutics, Inc. stock. As of the latest transaction made, Blue Owl Capital Holdings LP holds 4,166,829 shares of LRMR stock, worth $15.8 Million. This represents 9.0% of its overall portfolio holdings.
Number of Shares
4,166,829
Previous 3,859,468
7.96%
Holding current value
$15.8 Million
Previous $28 Million
2.46%
% of portfolio
9.0%
Previous 11.62%
Shares
4 transactions
Others Institutions Holding LRMR
# of Institutions
128Shares Held
67.3MCall Options Held
280KPut Options Held
76.3K-
Deerfield Management Company, L.P. (Series C) New York, NY21.2MShares$80.7 Million2.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.05MShares$23 Million0.55% of portfolio
-
Janus Henderson Group PLC London, X05.57MShares$21.2 Million0.02% of portfolio
-
Goldman Sachs Group Inc New York, NY4.25MShares$16.1 Million0.0% of portfolio
-
Chi Advisors LLC New York, NY3.41MShares$13 Million6.65% of portfolio
About Larimar Therapeutics, Inc.
- Ticker LRMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,269,200
- Market Cap $164M
- Description
- Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. T...